Bloomberg reporter Jason Leopold sued the FBI and DOJ for the files as part of a Freedom of Information Act request.

Officials will continue to hear feedback from residents and offer critiques on the design before finalization expected before the end of December.

Imagion Biosystems is on track for IND submission this month and a Phase 2 clinical trial in the US early ... Read More The ...

A Texas man is going to prison for life for sexually and physically abusing a child for years and having child sexual abuse ...

Associated Banc-Corp ( ASB) M&A Call December 1, 2025 8:30 AM EST ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

Unit 2 of the Doel nuclear power plant in Belgium's Flanders region has been taken offline for the final time after 50 years of operation and disconnected from the grid. Its closure is in line with ...

Belite linked tinlarebant to a 35.7% reduction in lesion growth rate versus placebo, achieving the study’s primary endpoint.

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical ...

Can you name a federal program responsible for creating or supporting 7 million high-paying jobs, attracting $75 billion in private investment, and generating $14.5 billion in tax revenue in the last ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...